Your browser doesn't support javascript.
loading
A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.
Pace, D; Snape, M; Westcar, S; Oluwalana, C; Yu, L-M; Begg, N; Wysocki, J; Czajka, H; Maechler, G; Boutriau, D; Pollard, A J.
Affiliation
  • Pace D; Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford, UK. dpace@mail.global.net.mt
Arch Dis Child ; 93(11): 963-70, 2008 Nov.
Article in En | MEDLINE | ID: mdl-18463125

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetanus Toxoid / Immunization, Secondary / Haemophilus Vaccines Type of study: Clinical_trials Limits: Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: Arch Dis Child Year: 2008 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetanus Toxoid / Immunization, Secondary / Haemophilus Vaccines Type of study: Clinical_trials Limits: Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: Arch Dis Child Year: 2008 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom